The liver scan in urologic oncology

Area of Science:

• Oncology
• Diagnostic Imaging
• Hepatology

Background:

• Hepatic metastases are a common complication of urologic malignancies.
• Accurate detection of liver metastases is crucial for staging and treatment planning.

Purpose of the Study:

• To evaluate the predictive value of liver scans in detecting hepatic metastases in patients with urologic malignancies.
• To compare the efficacy of liver scans with liver function tests for this purpose.

Main Methods:

• Retrospective review of 104 patients with urologic malignancies.
• Analysis of data from liver scans and serum alkaline phosphatase levels.

Main Results:

• Liver scans demonstrated a low predictive value for detecting hepatic metastases.
• Serum alkaline phosphatase alone showed a higher predictive value compared to liver scans.
• The cost-benefit ratio of liver scans was unfavorable.

Conclusions:

• Liver scans lack routine utility in the oncologic staging of urologic malignancies.
• Serum alkaline phosphatase is a more valuable biomarker for screening hepatic metastases in this patient population.